Jaguar Health (JAGX) Change in Inventory (2015 - 2026)
Jaguar Health's (JAGX) quarterly Change in Inventory came in at -$780000.0 in Q1 2026, down 473.21% year-on-year from $209000.0 in Q1 2025, and down 2589.66% on a QoQ basis from -$29000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Inventory (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Change in Inventory data on file, last reported at -$780000.0 in Q1 2026.
- On a quarterly basis, Change in Inventory fell 473.21% year-over-year to -$780000.0 in Q1 2026; TTM through Mar 2026 was -$735000.0, a 147.91% decrease from a year earlier, with the FY2025 full-year figure at $254000.0, down 78.03% from the prior year.
- Change in Inventory for Q1 2026 stood at -$780000.0, down from -$29000.0 in the prior quarter.
- Over the last five years, Change in Inventory for JAGX reached as high as $1.9 million in Q2 2022 and fell as low as -$780000.0 in Q1 2026.
- Historically, Change in Inventory has averaged $289352.9 across 5 years, with a median of $118000.0 in 2024.
- Across the five-year window, Change in Inventory jumped 7645.45% in 2023 and plunged 473.21% in 2026, its largest moves.
- Year by year, Change in Inventory stood at $423000.0 in 2022, then surged by 91.49% to $810000.0 in 2023, then fell by 17.16% to $671000.0 in 2024, then sank by 104.32% to -$29000.0 in 2025, then slumped by 2589.66% to -$780000.0 in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were -$780000.0 in Q1 2026, -$29000.0 in Q4 2025, and -$91000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 71.84 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | 97.70 Mn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -26.60 Mn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 3.32 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | -780,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -780,000.00 |
| Mar 31, 2026 | -780,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | -91,000.00 |
| Sep 30, 2025 | -91,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Dec 31, 2023 | 810,000.00 |
| Dec 31, 2023 | 810,000.00 |